Curida
PrivateLast Round
Growth Equity
Apr 15, 2024
Est. Valuation
$36.72M
Total Funding Raised
$22.49M
Company Overview
Curida is a pharmaceutical contract development and manufacturing organization (CDMO) that provides specialized services for the development and production of liquid medicines, biologics, and diagnostic solutions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Curida Comparables
Compare Curida with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Argonaut Manufacturing Services | 82% | |
| Adragos Pharma | 81% | |
| Unither Pharmaceuticals | 79% |
Curida Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Apr 15, 2024 | ||||
| Private Placement | Jan 22, 2018 |
Key People
Founding team and executive leadership
Curida Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Canica | Growth Equity, Private Placement |
| Farvatn | Growth Equity |
| Klaveness Marine | Growth Equity, Private Placement |
| Investinor | Growth Equity, Private Placement |
| Signet Healthcare Partners | Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 14, 2026
Grew 28% QoQ, from 74 to 95 employees.
- Jul 17, 2025
Grew 43% QoQ, from 67 to 96 employees.
Curida Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Curida's valuation, stock price, and market status.
Is Curida a public or private company?
Curida is a private company.
What is the current stock price of Curida?
Curida is a private company with no public stock price. Caplight tracks Curida's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Curida worth (valuation)?
Curida's valuation is estimated at $36.7M based on funding round data.
Can I buy Curida stock?
Curida shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Curida's last funding round?
Curida's most recent funding round was Growth Equity on April 15, 2024.
Who are the main investors in Curida?
Key investors in Curida include Signet Healthcare Partners.
Will Curida IPO soon?
No public IPO plans have been announced for Curida.
How can I track Curida secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Curida's secondary market activity and sign up for updates.